Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

May 23, 2023 by Alan Khadavi

Neffy, a New Epinephrine Nasal Spray and FMXIN002

Neffy is a new epinephrine intranasal spray being developed to treat severe allergic reactions such as anaphylaxis. Currently epinephrine is given in an injectable form under the names Epipen, Auvi-Q and others.

Recently and advisory council to the FDA recommended the approval of Neffy which has the same active ingredient as injectable epinephrine to be used for severe allergic reactions. If approved, it would be approved for adults above 66 pounds. Currently in the injectable form, the epinephrine dose is 0.3 milligrams, but the intranasal form would be dosed at 2 milligrams.

The trials performed by the drug manufacturer, ARS Pharma showed the results for Neffy “were neither substantially higher or lower than injectable epinephrine.” To measure the effects of Neffy, the trials showed that effects of blood pressure and heart rate were comparable to Epipen.

The FDA will likely make their decision in the middle of this year.

Advantages of this product is that there can be some hesitancy in patients to use an injectable epinephrine and an intranasal form could be more accepted. Also the device is a smaller than the injectable epinephrine products, which would make it easier to carry around and more widely accepted.

Some committee members are still hesitant to approve it because its hard to compare it to injectable epinephrine, as it has been being used since 1901.

There have many issues with the price of injectable epinephrine over the years, most notably with Epipen. There have been several generic versions that have come to the market that have made it more affordable.

There is no price for Neffy yet, but like all new medications that come to the market, the price usually is very high and usually manufacturers have coupons that bring down the price.

If and when Neffy is approved, it will be approved for adults, but the company is also working on a pediatric indication as well.

UPDATE SEPTEMBER 19, 2023

In a stunning announcement the FDA did not approve Neffy, they told ARS Pharmaceuticals that it needed to conduct another study before they could approve it. The FDA is going against the agency’s advisory committee which had recommended it in May. The FDA was most likely concerned by the lack of clinical data as it was not studied in people experiencing anaphylaxis. This kind of study would be hard to do for obvious reasons that you would not want a person to undergo anaphylaxis and potentially die during a study. And most studies need a placebo control, so if you do have a person who does undergo anaphylaxis for the study, giving them a placebo could potentially kill them as well.

The company plans to appeal the decision. The company said Neffy was comparable to the Epipen based on animal studies, as well as in people without anaphylaxis.

Update  November 14, 2023

Another nasal spray, FMXIN002 is a fast acting, dry powder, needle-free, intranasal epinephrine spray. It is another promising future treatment for anaphylaxis. A recent small study showed that it actually performed better than Epipen in several statistical categories. FMXIN002 is pocket-size, safe and could be a suitable alternative to injectable epinephrine too like Neffy. Larger clinical studies will be needed before approval and it would offer a potential advantage over current treatments.

Which is easier to use, Epipen or Auvi-Q?

Are Two EpiPens Really Necessary?

EpiPen Failure, can epinephrine injectors improve?

When do I use my Epipen?

Symjepi a cheaper alternative to Epipen, FDA Approved

Why is the Epipen Price so High?

Does an expired Epipen work?

Update March, 13, 2024

A recent study showed that the self administration of intranasal epi (neffy) resulted in pharmacokinetic and pharmacodynamic responses that were comparable or better than intramuscular epinephrine administered by health care providers. The results demonstrate that neffy may be a safe and easy to. use epinephrine delivery option that will be efficacious for the treatment of severe allergic reactions and anaphylaxis.

Filed Under: Blog, Headlines

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page